Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate Early to Hip Fracture Patients - Safe and Effective?
NCT05025293Phase 4Completed
- Start
- Dec 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zoledronate in hip fracture and osteoporosis (2 arms). Primary endpoint: Proportion of patients having P1NP > 35µg/L at 12 months. Started Dec 2021; status: completed.
02
Drugs
zoledronate
03
Conditions
hip fractureosteoporosis
Beyond the preview
Go deeper on NCT05025293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05025293.